Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03710239 · ClinicalTrials.gov registry record · NA
OPIOID Study - Pain With Osmotic Dilators
A NA study of Abortion in Second Trimester, sponsored by Albany Medical College.
- Completed
- Registry status
- NA
- Development phase
- 68
- Enrollment target
- 1
- Study location
NCT03710239 is a NA study of Abortion in Second Trimester that has completed, run by Albany Medical College. The registered enrollment target is 68 participants. The trial reports 1 study location across 1 state.
The verdict
NCT03710239, a NA study of Abortion in Second Trimester, has completed, sponsored by Albany Medical College.
- COMPLETED
- Registry status
- NA
- Development phase
- 68 participants
- Enrollment target
- 1
- Study location
Study Summary
Comparison of pain levels and pain medications utilized following insertion of two different types of osmotic dilators.
Conditions Studied
Interventions
- DEVICE Dilapan-S
- DEVICE Laminaria
Study Locations (1)
New York
- Albany Medical Center Obstetrics and Gynecology - Albany
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 68 participants |
| Start Date | 2018-10-02 |
| Est. Completion | 2020-03-11 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03710239
The ClinicalTrials.gov registry entry for NCT03710239 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 68 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Albany Medical College, which has 52 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Abortion in Second Trimester appearing as the primary indexed condition, and to 2 interventions - of which Dilapan-S is the first listed.
NCT03710239 reports 1 study location spanning 1 distinct geographic area - top geographies include New York.
Frequently Asked Questions
What is clinical trial NCT03710239 about?
NCT03710239 is a clinical study titled "OPIOID Study - Pain With Osmotic Dilators". Comparison of pain levels and pain medications utilized following insertion of two different types of osmotic dilators.
What is the current status of trial NCT03710239?
This trial is currently completed. It is a NA study. The enrollment target is 68 participants. The study started on 2018-10-02. Estimated completion is 2020-03-11.
What conditions does trial NCT03710239 study?
This clinical trial studies the following conditions: Abortion in Second Trimester.
What interventions are being tested in trial NCT03710239?
The interventions under investigation include: Dilapan-S (DEVICE), Laminaria (DEVICE).
Who is sponsoring clinical trial NCT03710239?
This trial is sponsored by Albany Medical College, which has 52 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT03710239 being conducted?
This trial has 1 study location across New York. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.